此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Innovative Brain-Computer Interface for People With Spinal Cord Injury (INTENSE-BCI)

2026年6月5日 更新者:Erik Aarnoutse, PhD、UMC Utrecht

Innovative Neurotechnology For Society - Brain-Computer Interface

The goal of this clinical trial is to demonstrate control of digital devices through a brain implant in people with spinal cord injury. The main question it aims to answer is efficient, independent, BCI-based control over digital devices in settings of daily living of an individual with SCI. In this project an advanced generation fully implantable BCI system will be used, the Brain InterChange (BIC) from CorTec.

Participants will be implanted with an electrode grid on the surface of the brain and an amplifier/transmitter on the skull, under the skin. Participation includes visits of researchers for recording and training at home, 1-3 times per week for one year. Extension of participation after one year is possible. If successful, the participant will be able to use the BCI at home independently, without the presence of a researcher.

研究概览

详细说明

Spinal Cord Injury (SCI) results in motor impairments in body parts innervated by the spinal cord below the site of the lesion. In addition to loss of leg movements, individuals with high cervical SCI experience significant impairments in arm and hand function (tetraplegia), impacting their access to digital devices, with obvious consequences for their ability to communicate, participate in society and the workforce, autonomously manage their life, and benefit from the entertainment options digital devices offer these days. Current assistive technologies (AT) for control over digital devices, such as voice control, eye-tracking, and head- or mouth-controlled devices, are often unintuitive, slow, limited in functionality, aesthetically unattractive, and they often interfere with regular movement or speech. An effective Brain-Computer Interface (BCI) would enable individuals with SCI to use movement-related neural signals to directly control digital devices, taking away the disadvantages of current AT. This would dramatically improve their quality of life.

The Brain InterChange from CorTec is an active implantable medical device for measurement of neuronal activity and electrical stimulation of the human nervous system, comprising an internal and an external unit. The internal unit consists of a small high-density ECoG grid with 32 contacts placed subdurally and a connected implantable amplifier/transmitter device that is placed subcutaneously. The external unit comprises a headpiece, for power transmission to the internal unit, a communication unit, that receives the data transmitted from the internal unit and controls the power transmission, and a USB cable, that connects the communication unit to the computer that has software to process and translate the brain data to a means of digital device control for SCI patients with custom in-house software developed during this study.

The BCI system also allows to provide users with somatosensory feedback about their motor attempts (in addition to the visual feedback), by delivering electrocortical stimulation (ECS) to the somatosensory regions of the brain. As such, the aim is to generate a more natural relation between intent (movement attempt of a body part) and effect (sensation in the same body part), which is expected to lead to fast training and accurate BCI performance.

研究类型

介入性

注册 (估计的)

1

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • Utrecht
      • Utrecht、Utrecht、荷兰、3584CX
        • 招聘中
        • University Medical Center Utrecht
        • 接触:
        • 接触:
        • 首席研究员:
          • Nick F Ramsey, PhD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Clinical diagnosis of SCI at the cervical level C4 or higher (C1-C4)
  • Complete or incomplete tetraplegia (quadriplegia) or tetraparesis (quadriparesis), i.e., level A or B at the American Spinal Injury Association (ASIA) Impairment Scale
  • Meeting surgical safety criteria, including surgical clearance by the study physicians
  • Meeting (neuro)psychological evaluation criteria
  • Ability to communicate reliably, via speech or other means
  • Willingness and ability to provide informed consent.
  • Lives within reasonable distance from UMC Utrecht
  • Participant consents to the study and still wishes to participate at the time of the study.
  • Vision and hearing largely intact.
  • For candidates who are not currently receiving invasive ventilation, and who have current respiratory problems (e.g., at night), there should be a clear and confirmed desire to proceed with tracheostomy ventilation whenever that would become necessary.

Exclusion Criteria:

  • Having a spinal cord injury with a degenerative or progressive etiology.
  • Having evident swallowing problems.
  • Having a significant current or recent anxiety disorder or depression or cognitive impairment that would interfere with obtaining informed consent or fully participating in study activities.
  • Medical conditions contraindicating surgery of a chronically implanted device or that could interfere with study participation (for example active infections, unexplained fever, existing scalp lesions or skin breakdown, osteomyelitis, hepatitis, any autoimmune disease/disorder, epilepsy, skin disorders causing excessive skin sloughing or poor wound healing, cranioplasty, significant cardiovascular, metabolic, or renal impairments, chronic oral or intravenous use of steroids or immunosuppressive therapy, active cancer within the past year or requires chemotherapy, uncontrolled autonomic dysreflexia within the past 3 months, hydrocephalus with or without an implanted ventricular shunt or a medical contraindication to stop anti-coagulant medications during surgery, or a catabolic state, or strong and frequent spasms)
  • Presence of pre-surgical findings in anatomical, functional, and/or vascular neuroimaging that makes achieving implant locations too challenging or incompatible with desired risk levels.
  • Inability to undergo MRI for pre-implantation evaluation, for example due to the presence of implanted devices that are incompatible with MRI, which may include pacemakers, cardiac defibrillators, spinal cord or vagal nerve stimulators, deep brain stimulators, and cochlear implants or devices that deliver diaphragm pacing.
  • Anticipated need for MRI after implantation of the Brain InterChange system.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:ECoG (electrocorticography) sensing
Use implantable ECoG-based Brain Computer interface to control digital devices
Implant electrodes and amplifier/transmitter and use, through amplifier and decoding, for control of BCI
其他名称:
  • Brain Interchange

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Effectiveness of BCI Control: Accuracy
大体时间:1 year
Accuracy: >80% sensitivity (true positive rate) for 1-command control; 80% classification accuracy (distinguishing between multiple classes) for multi-command control; and 80% classification accuracy and the correlation between the intended and actual response for multi-command continuous control
1 year
Efficiency of BCI control: Speed
大体时间:1 year
number of accurate selections made per minute
1 year
Efficiency of BCI control: Subjective Workload - Visual Analogue Scale
大体时间:1 year
Subjective Workload: Visual Analogue Scale Continuous scale: Little to no effort (0) - Much effort (5). Lower numbers are better.
1 year
Efficiency of BCI control: Subjective Workload - National Aeronautics and Space Administration-Task Load Index
大体时间:1 year
Subjective Workload: National Aeronautics and Space Administration-Task Load Index Scale: 21 point Likert-type scale. Lower numbers are better.
1 year
User satisfaction Quebec User Evaluation of Satisfaction with assistive Technology (QUEST)
大体时间:1 year

User Satisfaction: Quebec User Evaluation of Satisfaction with assistive Technology version 2.0.

Likert-type scale: Extremely dissatisfied - Dissatisfied - Slightly satisfied - Satisfied - Extremely satisfied. Extremely Satisfied is the best result.

1 year
user satisfaction Psychosocial impact of assistive devices scale (PIADS)
大体时间:1 year
User Satisfaction: Psychosocial impact of assistive devices scale. Likert-type scale -3, -2, -1, 0, 1, 2, 3. 3 is best result.
1 year
Stability of BCI performance: impedance
大体时间:1 year
Longitudinally follow the electrode impedance (in Ω), to assess their stability throughout the day and across the weeks and months after implantation.
1 year
Stability of BCI performance: signal dynamics
大体时间:1 year
Longitudinally follow the raw signal dynamics (in µV) of neural signals, to assess their stability throughout the day and across the weeks and months after implantation.
1 year
Stability of BCI performance: task-related modulation
大体时间:1 year
Longitudinally follow the task-related modulation in power (in µV), to assess their stability throughout the day and across the weeks and months after implantation.
1 year
Effects of somatosensory feedback on BCI Training and Performance: accuracy
大体时间:1 year
Compare BCI control accuracy (in %), including variability and improvement therein before and after applying somatosensory feedback through electrocortical stimulation of the somatosensory cortex
1 year
Effects of somatosensory feedback on BCI Training and Performance: neural signals
大体时间:1 year
Compare neural signal changes (in µV) in the sensorimotor areas before and after applying somatosensory feedback through electrocortical stimulation of the somatosensory cortex
1 year

次要结果测量

结果测量
措施说明
大体时间
Assess device specifications for future, larger-scale, application of HD ECoG-BCIs
大体时间:1 year
qualitative description on device specifications and experimental parameters, such as the specific decoder settings, for future, larger scale, application of HD ECoG-BCIs
1 year
Validation of software for independent home-use of advanced BCIs
大体时间:1 year

Validation: Questionnaire to evaluate user satisfaction and ease of use of the home use software.

Likert-type scale: fully disagree - disagree - neither agree or disagree - agree - fully agree - not applicable. Fully agree is the best result.

1 year

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 首席研究员:Nick F Ramsey, PhD、UMC Utrecht

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2027年8月1日

研究完成 (估计的)

2028年8月1日

研究注册日期

首次提交

2026年5月29日

首先提交符合 QC 标准的

2026年6月5日

首次发布 (实际的)

2026年6月11日

研究记录更新

最后更新发布 (实际的)

2026年6月11日

上次提交的符合 QC 标准的更新

2026年6月5日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

selected datasets will be available through a public repository after publication of results

IPD 共享时间框架

after first published results, no end date

IPD 共享访问标准

Publicly available

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅